儿童急性髓系白血病中的高白细胞血症——白细胞计数超过200×10⁹/L的挑战:NOPHO 1984-2014年经验
研究基于NOPHO登记库890例0-18岁急性髓系白血病患者,重点分析白细胞>200×10⁹/L的高白细胞血症。该组患者t(9;11)高频、8三体稀少,前2周死亡率30%远高于其他患者1%,总生存39%低于白细胞<200×10⁹/L组的61%,早期死因主要为颅内出血和白细胞淤滞,26%未启动抗白血病方案治疗。
要点
- 白细胞≥200×10⁹/L患者前2周死亡率30%,其他患者仅1%。
- 该组总生存39%,低于白细胞<200×10⁹/L组的61%。
- 26%的白细胞≥200×10⁹/L患者从未启动抗白血病方案治疗。
核心结论
- 诊断后最初数日内的死亡是高白细胞患者的主要挑战,作者主张快速启动强化化疗。
研究设计与样本
- 研究基于北欧儿童血液肿瘤学会(NOPHO)登记库,纳入1984-2014年登记的890例0-18岁急性髓系白血病患者,重点分析白细胞>200×10⁹/L者。
主要发现
- 86例(10%)白细胞100-199×10⁹/L,57例(6%)白细胞≥200×10⁹/L。
- 白细胞≥200×10⁹/L组t(9;11)频率高、8三体稀少。
- 白细胞≥200×10⁹/L组前2周死亡率为30%,其他所有患者为1%。
- 白细胞≥200×10⁹/L组总生存39%,白细胞<200×10⁹/L组为61%。
- 早期死亡主要原因为颅内出血和白细胞淤滞,26%的白细胞≥200×10⁹/L患者从未启动抗白血病方案治疗。
关键数值与推荐
- 高白细胞血症患者中24%接受了白细胞去除术或换血输血,对生存无影响。
- 高白细胞血症患者存活过第一周后,生存与白细胞较低者相同。
临床怎么用
- 作者主张对高白细胞患者快速启动强化化疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyperleucocytosis in paediatric acute myeloid leukaemia (AML) is associated with increased morbidity and mortality. We studied hyperleucocytosis in 890 patients with AML aged 0-18 years registered in the Nordic Society of Paediatric Haematology and Oncology (NOPHO) registry, with special focus on very high white blood cell counts (WBC >200 × 10/l). Eighty-six patients (10%) had WBC 100-199 × 109 /l and 57 (6%) had WBC ≥200 × 109 /l. Patients with WBC ≥200 × 109 /l had a high frequency of t(9;11) and a paucity of trisomy 8. Due to the high frequency of deaths within the first 2 weeks (30% vs. 1% for all others), overall survival in this group was inferior to patients with WBC <200 × 109 /l (39% vs. 61%). Main cause of early death was intracranial haemorrhage and leucostasis. Twenty-six per cent of these patients never started antileukaemic protocol therapy. Leukapheresis or exchange transfusion was used in 24% of patients with hyperleucocytosis without impact on survival. Patients with hyperleucocytosis surviving the first week had identical survival as patients with lower WBC. We conclude that death within the first days after diagnosis is the major challenge in patients with high WBC and advocate rapid initiation of intensive chemotherapy.
引用
- Zeller B, Glosli H, Forestier E, et al. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 109 /l. The NOPHO experience 1984-2014. Br J Haematol. 2017. PMID: 28542715. doi:10.1111/bjh.14692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。